Potej: A Potential Drug Target for Neurological Disorders (G653781)

Target Name: POTEJ

NCBI ID: G653781

POTEJ

Other Name(s): POTE2beta | POTE ankyrin domain family member J | POTEJ_HUMAN

Potej: A Potential Drug Target for Neurological Disorders

Potej (POTE2beta) is a protein that is expressed in various tissues of the body, including the brain, heart, liver, and kidneys. It is a key regulator of the blood-brain barrier and has been implicated in a number of neurological and cardiovascular diseases.

Recent studies have identified Potej as a potential drug target (or biomarker) for a number of diseases, including Alzheimer's disease, Parkinson's disease, and cardiovascular disease.

One of the key reasons for the interest in Potej as a drug target is its role in the regulation of the blood-brain barrier. The blood-brain barrier is a specialized barrier that separates the brain from the blood and helps to protect it from harmful substances. However, this barrier can also prevent the delivery of drugs to the brain, making it difficult to treat certain neurological and psychiatric disorders.

Potej has been shown to play a key role in the regulation of the blood-brain barrier. Studies have shown that Potej helps to control the movement of immune cells into the brain and that it can also help to reduce the amount of immune cells that enter the brain. This is important because immune cells can contribute to the development and progression of certain neurological and psychiatric disorders, such as Alzheimer's disease and Parkinson's disease.

In addition to its role in the blood-brain barrier, Potej has also been shown to be involved in a number of other important processes in the body. For example, it is involved in the regulation of cell growth, cell death, and the transport of nutrients into cells. It is also involved in the regulation of blood pressure and in the production of certain hormones that are important for maintaining normal levels of glucose in the body.

The potential benefits of targeting Potej as a drug target are significant. If successful, treatments that target Potej could be used to treat a wide range of neurological and psychiatric disorders, including Alzheimer's disease, Parkinson's disease, and cardiovascular disease. In addition, by studying the role of Potej in the regulation of the blood-brain barrier, researchers may also gain insights into the underlying mechanisms of these disorders and develop new treatments that target specific aspects of these processes.

Overall, Potej is a protein that has significant potential as a drug target (or biomarker) for a wide range of neurological and psychiatric disorders. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: POTE Ankyrin Domain Family Member J

The "POTEJ Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about POTEJ comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets